A California lupus sufferer said she was left embarrassed and in tears after she was denied a manicure at a nail salon due to her scars from the disease.
Jeniffer Dreyer Brown shared an emotional video in which she explained how she went to Happy Nails in Laguna Niguel, a city between Los Angeles and San Diego, on Friday to get her nails done.
It was the hottest day of the year, with temperatures reaching 110F, and Brown had worn a sundress, which exposed her blistered lupus scars, which are a result of previous flare-ups.
ImmuPharma PLC (LON:IMM) is headquartered in London and has its research operations in France (ImmuPharma (France) SA) and Switzerland (ImmuPharma AG). ImmuPharma is dedicated to the development of innovative drugs to treat serious medical conditions, characterised by High unmet medical need, Low marketing costs and Relatively low development costs.
Founded first in Basel, Switzerland in 1999 and led by an experienced management team, ImmuPharma now has important R&D collaboration arrangements with highly respected health and medical research laboratories in Europe. The company plans either to bring its drug candidates to market itself, or to license them in corporate deals to other pharmaceutical companies.